Study of Leuprolide Acetate Injectable Suspension in the Treatment of Central Precocious Puberty

NCT02452931 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Precocious Puberty, Central

Interventions

DRUG: Leuprolide Acetate 45 mg

Sponsor

Tolmar Inc.